Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Septerna, Inc.NASDAQ: SEPN
Total Equity · Q3 FY2026 · quarter ended Sep 2026
Total equity rises 10.1% from a year ago
Total equity stood at $427.93M at the end of Q3 FY2026, up 10.1% from a year earlier and up 10.7% from the prior quarter.
Context
- Total equity amounted to 69.1% of total assets at the end of Q3 FY2026, up 5.0 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +10.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 381.93M USD
- Year-over-year change
- -9.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 381.93M | -9.1% |
| FY2024 | 2024-12-31 | 420.05M | +1194.6% |
| FY2023 | 2023-12-31 | (38.37M) | +13.2% |
| FY2022 | 2022-12-31 | (44.2M) | — |
Total Equity vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 total equity of $427.93M is the 4th highest of the 7 companies compared; the peer median is $407.32M.
- Its year-over-year change of +10.1% is the 5th highest of 6, against a peer median of +22.0%.
- Total equity amounts to 69.1% of total assets for SEPN, versus a peer median of 91.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.35B | +75.4% | — | 95.0% | |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $1.12B | — | — | 92.3% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $472.95M | +22.0% | — | 94.5% |
SEPNSepterna, Inc. | Sep 2026 | $427.93M | +10.1% | — | 69.1% |
| Mar 2026 | $341.7M | +17.0% | +51.8% | 81.4% | |
| Mar 2026 | $89.96M | +911.1% | +122.6% | 91.0% | |
| Mar 2026 | $18.72M | -34.9% | -35.2% | 40.4% | |
| Peer median (excluding SEPN) | $407.32M | +22.0% | +51.8% | 91.7% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.